Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A24128 | 23203089 | Int J Mol Sci | Non-alcoholic fatty liver disease is not related to the incidence of diabetic nephropathy in Type 2 Diabetes. | 2012 | Details |
A24129 | 23201248 | J Hepatol | Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease. | 2012 | Details |
A24130 | 23198569 | Nihon Rinsho | [Pediatric nonalcoholic fatty liver disease/nonalcoholic steatohepatitis]. | 2012 | Details |
A24131 | 23197979 | Gastroenterol Res Pract | Nutrition therapy for liver diseases based on the status of nutritional intake. | 2012 | Details |
A24132 | 23197411 | Gut | Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. | 2012 | Details |
A24133 | 23197236 | Med Sci Monit | The BARD score and the NAFLD fibrosis score in the assessment of advanced liver fibrosis in nonalcoholic fatty liver disease. | 2012 | Details |
A24134 | 23195951 | Biochim Biophys Acta | High fat diets and pathology in the guinea pig. Atherosclerosis or liver damage? | 2012 | Details |
A24135 | 25755455 | J Clin Exp Hepatol | A Randomized Controlled Trial Comparing Efficacy of Pentoxifylline and Pioglitazone on Metabolic Factors and Liver Histology in Patients with Non-alcoholic Steatohepatitis. | 2012 | Details |
A24136 | 23190589 | Med Sci Sports Exerc | Cardiorespiratory fitness, waist circumference, and alanine aminotransferase in youth. | 2013 | Details |
A24137 | 23190373 | Acta Paediatr | Fatty liver is a good indicator of subclinical atherosclerosis risk in obese children and adolescents regardless of liver enzyme elevation. | 2012 | Details |
A24138 | 23188092 | J Gastroenterol | Oral contraceptive pill use is associated with reduced odds of nonalcoholic fatty liver disease in menstruating women: results from NHANES III. | 2012 | Details |
A24139 | 23185655 | J Cardiovasc Ultrasound | Relationship between Nonalcoholic Fatty Liver Disease and Carotid Artery Atherosclerosis Beyond Metabolic Disorders in Non-Diabetic Patients. | 2012 | Details |
A24141 | 23185203 | Arch Med Sci | Metformin and its clinical use: new insights for an old drug in clinical practice. | 2012 | Details |
A24142 | 23184095 | J Gastroenterol | Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal alanine aminotransferase levels. | 2012 | Details |
A24143 | 23183525 | J Hepatol | Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. | 2012 | Details |
A24144 | 23183522 | J Hepatol | Non-alcoholic steatohepatitis: the role of oxidized low-density lipoproteins. | 2012 | Details |
A24145 | 23182413 | Epilepsy Res | The novel insulin resistance parameters RBP4 and GLP-1 in patients treated with valproic acid: just a sidestep? | 2012 | Details |
A24146 | 23179302 | Clin Exp Med | Serum asymmetric dimethylarginine levels are independently associated with procollagen III N-terminal peptide in nonalcoholic fatty liver disease patients. | 2012 | Details |
A24147 | 23178979 | J Hepatol | Cardiac structure and function are altered in adults with non-alcoholic fatty liver disease. | 2012 | Details |
A24148 | 23178552 | Prog Lipid Res | Molecular mechanisms and the role of saturated fatty acids in the progression of non-alcoholic fatty liver disease. | 2012 | Details |
A24149 | 23177332 | Rev Esp Med Nucl Imagen Mol | Evaluation of hepatic metabolic activity in non-alcoholic fatty livers on 18FDG PET/CT. | 2012 | Details |
A24151 | 23176674 | BMC Med Genet | Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population. | 2012 | Details |
A24152 | 23175777 | J Lipid Res | Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat. | 2012 | Details |
A24153 | 23175136 | Hepatology | Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. | 2013 | Details |
A24154 | 23174781 | Hepatology | Resistin reduces mitochondria and induces hepatic steatosis in mice by the protein kinase C/protein kinase G/p65/PPAR gamma coactivator 1 alpha pathway. | 2013 | Details |
A24155 | 23174676 | Acta Biochim Biophys Sin (Shanghai) | Antioxidant effect of apolipoprotein A-I on high-fat diet-induced non-alcoholic fatty liver disease in rabbits. | 2012 | Details |
A24156 | 23174488 | Clin Biochem | Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease. | 2012 | Details |
A24157 | 23174203 | Proc Nutr Soc | The gut microbial metabolome: modulation of cancer risk in obese individuals. | 2012 | Details |
A24158 | 23172799 | J Magn Reson Imaging | Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging. | 2012 | Details |
A24159 | 23169785 | Am J Physiol Endocrinol Metab | Pex11α deficiency impairs peroxisome elongation and division and contributes to nonalcoholic fatty liver in mice. | 2012 | Details |
A24160 | 23166534 | Hepat Mon | Hepatocellular carcinoma in pakistan: where do we stand? | 2012 | Details |
A24161 | 23165995 | Mol Nutr Food Res | miRNAs, polyphenols, and chronic disease. | 2012 | Details |
A24162 | 23165534 | Nutr Hosp | Possible molecular mechanisms soy-mediated in preventing and treating nonalcoholic fatty liver disease. | 2013 | Details |
A24163 | 23163663 | Aliment Pharmacol Ther | Safety and efficacy of liraglutide in patients with type 2 diabetes and elevated liver enzymes: individual patient data meta-analysis of the LEAD program. | 2012 | Details |
A24164 | 23130907 | Physiol Res | Steatotic rat hepatocytes in primary culture are more susceptible to the acute toxic effect of acetaminophen. | 2012 | Details |
A24165 | 23159641 | Life Sci | Nonalcoholic fatty liver disease: current and potential therapies. | 2012 | Details |
A24166 | 23158933 | Fertil Steril | Psoriatic patients have an increased risk of polycystic ovary syndrome: results of a cross-sectional analysis. | 2012 | Details |
A24167 | 23158500 | J Crohns Colitis | Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease. | 2012 | Details |
A24168 | 23158405 | J Surg Res | Lysophospholipid variants in hepatocellular carcinoma. | 2012 | Details |
A24171 | 23155331 | World J Gastroenterol | PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease. | 2012 | Details |
A24172 | 23154483 | J Pediatr Gastroenterol Nutr | Levels of serum ceruloplasmin associate with pediatric nonalcoholic fatty liver disease. | 2013 | Details |
A24173 | 23152415 | Clin Chem Lab Med | High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis. | 2013 | Details |
A24174 | 23148186 | Ther Adv Endocrinol Metab | An Endocrine Perspective of Nonalcoholic Fatty Liver Disease (NAFLD). | 2011 | Details |
A24175 | 23147992 | Br J Surg | Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome. | 2012 | Details |
A24176 | 23146095 | Liver Int | Combined paediatric NAFLD fibrosis index and transient elastography to predict clinically significant fibrosis in children with fatty liver disease. | 2012 | Details |
A24177 | 23145208 | Am J Transl Res | Circulating levels of citrullinated and MMP-degraded vimentin (VICM) in liver fibrosis related pathology. | 2012 | Details |
A24178 | 23144979 | PLoS One | The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease. | 2012 | Details |
A24179 | 23143735 | Dig Dis Sci | Anthropometric and clinical factors associated with mortality in subjects with nonalcoholic fatty liver disease. | 2012 | Details |
A24180 | 23142626 | Gastroenterology | Central melanin-concentrating hormone influences liver and adipose metabolism via specific hypothalamic nuclei and efferent autonomic/JNK1 pathways. | 2012 | Details |
A24181 | 23142622 | J Hepatol | Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease. | 2012 | Details |
A24182 | 23142063 | J Hepatol | High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease: a 3-year prospective study in China. | 2012 | Details |
A24183 | 23142062 | J Hepatol | Non-alcoholic steatohepatitis: a non-invasive diagnosis by analysis of exhaled breath. | 2012 | Details |
A24184 | 23141894 | Clin Res Hepatol Gastroenterol | Treatment of NASH with ursodeoxycholic acid: cons. | 2012 | Details |
A24185 | 23141893 | Clin Res Hepatol Gastroenterol | Treatment of NASH with ursodeoxycholic acid: pro. | 2012 | Details |
A24186 | 23141876 | Int J Cardiol | Non-alcoholic fatty liver disease and cardiovascular risk. | 2012 | Details |
A24187 | 23141586 | Atherosclerosis | The effect of obesity on the association between liver fat and carotid atherosclerosis in a multi-ethnic cohort. | 2012 | Details |
A24188 | 23140546 | Curr Vasc Pharmacol | The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study. | 2013 | Details |
A24189 | 23139599 | World J Gastroenterol | Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. | 2012 | Details |
A24190 | 23137022 | Scand J Gastroenterol | Hepatic expression and serum levels of syndecan 1 (CD138) in patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24191 | 23136827 | Biomarkers | Higher hepatic gene expression and serum levels of matrix metalloproteinase-2 are associated with steatohepatitis in non-alcoholic fatty liver diseases. | 2012 | Details |
A24192 | 23134956 | Zhonghua Yi Xue Za Zhi | [Clinical analysis of hepatitis B virus mutations related to adefovir dipivoxil among patients with chronic hepatitis B virus infection in eastern Zhejiang province]. | 2012 | Details |
A24193 | 23134937 | BMC Pediatr | Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes. | 2012 | Details |
A24194 | 23134073 | Clin Endocrinol (Oxf) | Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives. | 2013 | Details |
A24195 | 23131380 | Complement Ther Med | The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders. | 2012 | Details |
A24197 | 23129794 | J Physiol | The role of fructose transporters in diseases linked to excessive fructose intake. | 2012 | Details |
A24199 | 23128368 | Am J Nephrol | Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988-1994. | 2012 | Details |
A24200 | 23127599 | Food Chem Toxicol | Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats. | 2012 | Details |
A24201 | 23127227 | Clin Exp Pharmacol Physiol | Thiazolidinediones improve hepatic fibrosis in rats with non-alcoholic steatohepatitis by activating the adenosine monophosphate-activated protein kinase signalling pathway. | 2012 | Details |
A24203 | 23126674 | Transpl Int | Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantation. | 2012 | Details |
A24205 | 23124044 | Gene | cDNA cloning and the response to overfeeding in the expression of stearoyl-CoA desaturase 1 gene in Landes goose. | 2012 | Details |
A24206 | 23123503 | Biochimie | Fibroblast growth factor 21 is induced by endoplasmic reticulum stress. | 2012 | Details |
A24207 | 23123425 | Food Chem Toxicol | Dietary quercetin ameliorates nonalcoholic steatohepatitis induced by a high-fat diet in gerbils. | 2012 | Details |
A24208 | 23121401 | Liver Int | Liver involvement in Turner syndrome. | 2012 | Details |
A24209 | 23120807 | Acta Med Croatica | [Relationship between nonalcoholic fatty liver disease markers and renal function in patients with type 1 diabetes]. | 2011 | Details |
A24210 | 23118937 | PLoS One | Perinatal exposure to a high-fat diet is associated with reduced hepatic sympathetic innervation in one-year old male Japanese macaques. | 2012 | Details |
A24211 | 23117851 | Medicine (Baltimore) | Nonalcoholic fatty liver disease in lean individuals in the United States. | 2012 | Details |
A24212 | 23113697 | Fundam Clin Pharmacol | Pharmacokinetics of cysteamine bitartrate following intraduodenal delivery. | 2012 | Details |
A24213 | 23113131 | Iran J Public Health | Relationship between Serum Aminotransferase Levels and Metabolic Disorders in Northern China. | 2012 | Details |
A24214 | 23113121 | Iran J Public Health | Association between Insulin Resistance, Metabolic Syndrome and Nonalcoholic Fatty Liver Disease in Chinese Adults. | 2012 | Details |
A24215 | 23113103 | Iran J Public Health | An exploration of prevalence and associated factors of nonalcoholic Fatty liver disease in the taiwanese police service. | 2011 | Details |
A24217 | 23112047 | J Biol Chem | Role of Pin1 protein in the pathogenesis of nonalcoholic steatohepatitis in a rodent model. | 2012 | Details |
A24218 | 23110104 | PLoS One | E4orf1 improves lipid and glucose metabolism in hepatocytes: a template to improve steatosis & hyperglycemia. | 2012 | Details |
A24219 | 23110065 | PLoS One | Dietary protein affects gene expression and prevents lipid accumulation in the liver in mice. | 2012 | Details |
A24220 | 23110056 | PLoS One | Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults. | 2012 | Details |
A24221 | 23108307 | Dig Dis | Adipocytokines and hepatocellular carcinoma. | 2012 | Details |
A24222 | 23108199 | Curr Opin Endocrinol Diabetes Obes | Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome. | 2012 | Details |
A24223 | 23108115 | J Hepatol | Pharmacological inhibition of adipocyte fatty acid binding protein alleviates both acute liver injury and non-alcoholic steatohepatitis in mice. | 2012 | Details |
A24224 | 23107446 | J Dig Dis | Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease. | 2012 | Details |
A24225 | 23101984 | Clin Liver Dis | Alcohol's effect on other chronic liver diseases. | 2012 | Details |
A24226 | 23094755 | J Gastroenterol Hepatol | Nonalcoholic fatty liver disease in Asia: a story of growth. | 2013 | Details |
A24227 | 23092327 | Curr Pharm Des | Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD). | 2013 | Details |
A24228 | 23091922 | Rev Med Brux | [Non alcoholic fatty liver disease assessment]. | 2012 | Details |
A24229 | 23075871 | Dig Dis | Clinical spectrum and therapy of non-alcoholic steatohepatitis. | 2012 | Details |
A24230 | 23075870 | Dig Dis | Nonalcoholic fatty liver disease: what the pathologist can tell the clinician. | 2012 | Details |
A24231 | 23073871 | Intern Emerg Med | Nonalcoholic fatty liver disease and atherosclerosis. | 2012 | Details |
A24232 | 23073870 | Intern Emerg Med | Non-alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences. | 2012 | Details |
A24233 | 23073869 | Intern Emerg Med | Ultrasonography (US) and non-invasive diagnostic methods for non-alcoholic fatty liver disease (NAFLD) and early vascular damage. Possible application in a population study on the metabolic syndrome (MS). | 2012 | Details |
A24234 | 23091812 | Clin Mol Hepatol | Type and cause of liver disease in Korea: single-center experience, 2005-2010. | 2012 | Details |
A24235 | 23091808 | Clin Mol Hepatol | Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH. | 2012 | Details |
A24236 | 23090329 | Nat Rev Gastroenterol Hepatol | Physical activity: an essential component of lifestyle modification in NAFLD. | 2012 | Details |